Gender Male
Age 51
Nationality Malaysian

Appointed on 1 March 2024
Date of last re-election 13 June 2022

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year 2/2

Board Skills and Experience Matrix
Corporate Planning & Development
Legal & Law

Working Experience and Occupations
Zulkifli's career began as a legal counsel at Panglima Aces Sdn Bhd in 1997. Rapidly ascending the ranks, he distinguished himself as an advocate and solicitor at Messrs Raslan Loong within the same year and by 2002, Zulkifli became a partner at Messrs Rashid Zulkifli. Beyond his legal practice, Zulkifli serves as a director and major shareholder of MMA Resources Sdn Bhd, an oil & gas company.

In addition to his corporate responsibilities, Zulkifli is actively engaged in shaping the landscape of development and governance. Currently, he holds the positions of Chairman and Director at Era Universe Development Sdn Bhd, a development company.

Zulkifli had served as the Legal Advisor for Johor State Government Linked Companies (GLC). His diverse portfolio included directorships in esteemed organisations such as the Cooperative Commission of Malaysia, the regulator body of cooperatives in the country; Board of Trustee of the Foundation of Research and Transformation, an independent think tank research body of the Prime Minister’s Office; and Songa Offshore Malaysia Sdn Bhd.

Internationally, Zulkifli was a director and management member of the Chartridge Conference Centre (UK) Limited, overseeing the operations of four hotels and conference centres in the United Kingdom.

In 2021, Zulkifli assumed the position of Chairman at Idaman Pharma Manufacturing Sdn Bhd, a subsidiary of Pharmaniaga Berhad (Pharmaniaga) and subsequently, appointed as the Executive Director of Pharmaniaga in March 2022. In February 2023, he was redesignated as Deputy Chief Executive Officer of Pharmaniaga.

On 1st March 2024, Zulkifli was appointed as the Executive Director of Pharmaniaga, taking over the role and functions of the Executive Committee which was subsequently dissolved.

Qualification(s)
• Admission to Malaysian Bar in 1996
• Advocate and Solicitor of the High Court of Malaya
• Certified Patent Agent
• Bachelor of Laws, Universiti Islam Antarabangsa Malaysia

Gender Male
Age 52
Nationality Malaysian

Appointed on 20 November 2020
Date of last re-election 12 June 2023

Board Committee(s)
• Chairman of Nominating and Remuneration Committee
• Chairman of Sustainability Committee
• Member of Audit Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings financial year 22/22

Board Skills and Experience Matrix
Legal & Law
Human Resources

Working Experience and Occupations
Dr. Abdul Razak Ahmad is the Founding Director of Bait Al Amanah, a political development think tank in Kuala Lumpur.

He is currently appointed as Chairman of Education Malaysia Global Services and a member of the Board of Directors at Universiti Malaysia Sarawak (UNIMAS). He is also a member of the Consultative Council on Foreign Policy, Ministry of Foreign Affairs.

He previously served as Special Advisor to the Minister of Higher Education Malaysia, Advisor to the Chief Minister of Johor and a consultant to the special consultancy team on globalisation at the National Economic Action Council (NEAC) of the Prime Minister’s Department.

Dr. Abdul Razak was also a faculty member at the National Defence University of Malaysia, teaching international security, international law and global affairs. He is an Adjunct Professor at Universiti Sains Malaysia at present.

On the international front, Dr. Abdul Razak has served as a consultant and policy advisor in international development projects in Bahrain, Libya, Tunisia, Palestine, Indonesia, the Philippines, Vietnam, Fiji, Papua New Guinea and Timor Leste. He also used to serve as the resource person for the European Union and the World Bank on human development and human security-related issues.

He is a qualified legal counsel and received his PhD in Law and International Security from the University of Leeds, UK. He did his fellowship at East West Centre (University of Hawaii) and was a visiting researcher at Colombia University. He also attended leadership executive programmes at Said Business School (Oxford University) and Kennedy School of Government (Harvard University).

On 22 February 2023, Dr. Abdul Razak was redesignated as Senior Independent Non- Executive Director of Pharmaniaga.

Qualification(s)
• Doctor of Philosophy (DPhil) in Law (International Security), University of Leeds, United Kingdom
• Masters in LLM (International Trade Law), University of Kent at Canterbury, United Kingdom
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia

Gender Female
Age 49
Nationality Malaysian

Appointed on 20 August 2021
Date of last re-election 13 June 2022

Board Committee(s)
• Chairman of Audit Committee
• Chairman of Board Tender Committee
• Member of Nominating and Remuneration Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Reneuco Berhad
• PT Millennium Pharmacon International Tbk

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year 22/22

Board Skills and Experience Matrix
Accounting & Finance
Corporate Planning & Development

Working Experience and Occupations
Sarah has over 22 years of experience in corporate finance transactions involving equity issuance, mergers and acquisitions, corporate restructuring and corporate valuation. She began her career in investment banking with Malaysian International Merchant Bankers Berhad in 2001 after obtaining her professional qualifications from PricewaterhouseCoopers.

Later in her career, she joined other banking institutions in Malaysia such as AmInvestment Bank Berhad, Aseambankers Berhad (now known as Maybank Investment Bank Berhad) and RHB Investment Bank Berhad.

Presently, Sarah sits as Executive Director of Reneuco Berhad and is also the Executive Director of 3p Capital Advisers Sdn. Bhd., a company licensed with the Securities Commission Malaysia that provides advisory services to the capital market players.

Qualification(s)
• Certified Practising Accountant, CPA Australia
• Capital Markets Services Representative’s License (CMSRL)
• Degree in Bachelor of Commerce (Accounting), University of Canberra, Australia

Gender Male
Age 41
Nationality Malaysian

Appointed on 22 February 2023
Date of last re-election None

Board Committee(s)
• Member of Audit Committee
• Member of Nominating and Remuneration Committee
• Member of Board Risk and Investment Committee
• Member of Sustainability Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year 20/20

Board Skills and Experience Matrix
Accounting & Finance
Corporate Planning & Development
Business & Economics

Working Experience and Occupations
Ahmad Shahredzuan began his career at Permodalan Nasional Berhad in 2006. His last position was Senior Manager at the Office of President and Group Chief Executive. Subsequently, he joined McKinsey & Company in 2015 as an Implementation Consultant, where he was involved in the strategy and execution of numerous projects.

In 2019, he expanded his horizon by joining Boustead Holdings Berhad (Boustead) as Senior General Manager. He then rose in the ranks within the Boustead Group to Chief Transformation Officer in May 2020. In March 2021, Ahmad Shahredzuan was appointed as Chief Reinvention and Strategy Officer of Boustead and later redesignated to Group Chief Reinvention and Strategy Officer effective March 2023.

He holds a Bachelor of Economics from the University of Warwick, United Kingdom and obtained his Graduate Diploma of Applied Finance from Kaplan Higher Education in Australia.

On 22 February 2023, he was appointed as Non-Independent Non-Executive Director of Pharmaniaga.

Qualification(s)
• Graduate Diploma of Applied Finance, Kaplan Higher Education, Australia
• Bachelor of Economics, University of Warwick, United Kingdom

Gender Male
Age 46
Nationality Malaysian

Appointed on 10 August 2023
Date of last re-election None

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Affin Bank Berhad

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year 4/4

Board Skills and Experience Matrix
Accounting & Finance

Working Experience and Occupations
Mohammad Ashraf started his career at Ernst & Young, Ireland as an auditor in 2002. He then joined CUNA Mutual Life Assurance (Europe) Limited in Ireland as a Financial Accountant for the European region from 2005 to 2007 and then shifted his focus to the banking industry as a Regulatory Reporting Analyst with UBS Investment Bank, United Kingdom from 2007 to 2009.

In 2009, he set his footing in Malaysia by joining Prokhas Sdn Bhd as Associate Director for the Capital Market where he stayed until 2013. He then moved on to Johawaki Holdings Sdn Bhd where he was the General Manager of Finance Special Projects until 2015.

His depth of knowledge and experience in finance led him to become the Associate Director, Corporate Advisory and Structuring at MIDF Amanah Investment Bank from 2015 to 2016.

In 2016, Mohammad Ashraf join Ahmad Zaki Resources as General Manager on Corporate Finance before he was subsequently appointed as the Chief Financial Officer from 2017 to 2020.

He later joined Lembaga Tabung Angkatan Tentera (LTAT) in 2020 as the Chief Financial Officer. Subsequently, on 1 April 2024, he was appointed as the Chief Executive.

Mohammad Ashraf holds a Bachelor of Accountancy from Universiti Tenaga Nasional Malaysia and is a Chartered Accountant with the Malaysian Institute of Accountants as well as a member of the Association of Chartered Certified Accountants.

Qualification(s)
• Chartered Accountant, Malaysian Institute of Accountants
• Member of Association of Chartered Certified Accountants
• Bachelor of Accountancy (Hons), University Tenaga Nasional

Gender Male
Age 48
Nationality Malaysian

Appointed on 1 March 2024
Date of last re-election None

Board Committee(s)
• Chairman of Board Risk and Investment Committee
• Member of Audit Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Mycron Steel Berhad
• Olympia Industries Bhd

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings financial year N/A

Board Skills and Experience Matrix
Accounting & Finance

Working Experience and Occupations
Dato’ Mohd Zahir has over 27 years of experience in accounting, finance and asset management. He established his career as an auditor with various accounting firms including PricewaterhouseCoopers and Deloitte & Touche in both of its Malaysia and overseas offices. He was the Chief Financial Officer of Tracoma Holdings Berhad, a company focusing on the manufacturing of automotive components before appointed as the Audit Director for Baker Tilly Monteiro Heng. Dato’ Mohd Zahir subsequently held the position of Head of Operations of Principal Asset Management Berhad (formerly known as CIMB-Principal Asset Management Berhad).

Dato’ Mohd Zahir then joined Prasarana Malaysia Berhad (Prasarana) as the Group Chief Financial Officer and was promoted to Chief Executive Officer of Prasarana Integrated Development (PRIDE), a whollyowned subsidiary of Prasarana. Dato’ Mohd Zahir subsequently became the Managing Director of Zahir Irkaz Advisory PLT and then appointed as Managing Director and Group Chief Executive Officer of Destini Berhad.

Dato’ Mohd Zahir graduated with a Bachelor of Commerce (Accounting) degree from the University of New South Wales, Australia. He attended Oxford Global CEO Programme at Said Business School, Oxford University, England. He is a Certified Financial Planner, a fellow of the Chartered Accountants Australia & New Zealand and a member of Malaysian Institute of Accountants.

Currently, Dato’ Mohd Zahir is the Chairman of Universiti Malaya Medical Centre and the Independent Non-Executive Director and Audit Committee Chairman of Universiti Malaya. He also sits as a Independent Non- Executive Director of Mycron Steel Berhad and Olympia Industry Berhad.

Qualification(s)
• Certified Financial Planner
• Fellow, Chartered Accountants Australia & New Zealand
• Degree in Bachelor of Commerce (Accounting), University of New South Wales, Australia

Gender Female
Age 62
Nationality Malaysian

Appointed on 1 March 2024
Date of last re-election None

Board Committee(s)
• Member of Nominating and Remuneration Committee
• Member of Sustainability Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year N/A

Board Skills and Experience Matrix
Legal & Law
Medical & Pharmaceuticals

Working Experience and Occupations
Dato’ Dr. Faridah brings to the Board over 37 years of experience in pharmaceutical industry involving pharmacy development, regulatory compliance and drug management.

Dato’ Dr. Faridah started her career with the National Pharmaceutical Control Bureau in 1986 upon graduating with a Bachelor’s degree in Pharmacy from the Universiti Sains Malaysia. She has held several important posts in the Government sector, namely at the Ministry of Health, Kuala Lumpur Hospital and the National Pharmaceutical Regulatory Agency. Upon her departure from the Ministry, she was appointed as an Academic Fellow at the School of Pharmaceutical Sciences, Universiti Sains Malaysia from June 2021 to May 2023.

In addition to her degree and Diploma in Medical Microbiology from the Institute for Medical Research, Dato’ Dr. Faridah received her Master of Science degree in Pharmaceutical Services and Medicines Control from the University of Bradford, United Kingdom. She later pursued and received her Doctor of Philosophy (Ph.D) in Pharmacoeconomics from the Universiti Sains Malaysia in 2006.

Qualification(s)
• Doctor of Philosophy (Ph.D) in Pharmacoeconomics, Universiti Sains Malaysia
• Master of Science in Pharmaceutical Services and Medicines Control, University of Bradford, United Kingdom
• Diploma in Medical Microbiology, Institute for Medical Research, Malaysia
• Bachelor of Pharmacy (Honours), Universiti Sains Malaysia

Gender Male
Age 59
Nationality Indonesian

Appointed on 1 March 2024
Date of last re-election None

Board Committee(s)
• Member of Nominating and Remuneration Committee
• Member of Audit Committee
• Member of Sustainability Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year N/A

Board Skills and Experience Matrix
Business & Economics
Medical & Pharmaceuticals

Working Experience and Occupations
Drs. Imam brings a wealth of experience and expertise to the Board, backed by a strong educational foundation and decades of professional journey in the pharmaceutical industry.

With extensive expertise spanning marketing and sales strategy, business strategy, retail, pharmaceuticals, business development, and healthcare, he brings a multifaceted skill set to the boardroom, poised to drive strategic initiatives and propel organisational success to new heights.

Having earned a Bachelor’s degree in Pharmacy in 1989, Drs. Imam embarked on a career journey in the pharmaceutical line. Fuelled by a passion for innovation and strategic foresight, he pursued a Master’s in Strategic Management to equip himself with the knowledge and skills necessary for navigating the complexities of modern business landscapes.

In 2011, he was made the Managing Director of PT Kimia Farma Apotek. Subsequently, Drs. Imam’s transition to the role of Business Development Director at PT Kimia Farma Tbk in 2019, demonstrated his versatility and ability to adapt to new challenges and provided him with invaluable insights into forging strategic partnerships and driving sustainable growth initiatives.

Recognised for his exceptional contributions, Drs. Imam assumed the position of Marketing & Commercial Director in 2021, further highlighting his proficiency in creating robust marketing and sales strategies to grasp the evolving market dynamics.

Throughout his illustrious career, Drs. Imam has been instrumental in clinching numerous accolades in the pharmaceutical sector in Indonesia, especially in marketing.

Qualification(s)
• Masters in Strategic Management, PPM Higher Management School, Indonesia
• Degree in Pharmacy, University of Airlangga, Indonesia

Gender Male
Age 37
Nationality Malaysian

Appointed on 20 May 2024
Date of last re-election None

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered into any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Board Meetings attended in the financial year N/A

Board Skills and Experience Matrix
None

Working Experience and Occupations
March 2023 to Current - Vice President, Corporate Finance at Lembaga Tabung Angkatan Tentera; November 2021 to February 2023 - Senior Manger, Growth & Strategy at Capital A Berhad; June 2016 to October 2021 - Head of Business Development, Group Strategy at Naza Corporation Holdings Sdn Bhd; September 2019 to April 2020 - Interim Head of Company, Naza Communications Sdn Bhd; July 2014 to May 2016 - Assistant Manager, Corporate Planning at UEM Sunise Berhad; January 2013 to June 2014 - Assistant Manager, Managing Director's Office at UEM Edgenta Berhad; January 2012 to December 2012 - Senior Executive, Operations Control at UEM Edgenta Berhad; January 2011 to December 2011 - Executive, Corporate Strategy & Business Development at UEM Edgenta Berhad; June 2009 to December 2010 - Engineer, Operations & Maintenance at UEM Edgenta Berhad.

Qualification(s)
• Master of Management, Universiti Tun Abdul Razak Higher Management School, Indonesia
• Bachelor of Chemical Engineering, Universiti Putra Malaysia